We exist to improve the lives
of everyone affected by epilepsy

Warning message

  • This article was published in January 2015. The information may be out of date. Please check our epilepsy information or our site A-Z.
  • This article was published in October 2014. The information may be out of date. Please check our epilepsy information or our site A-Z.
  • This article was published in September 2013. The information may be out of date. Please check our epilepsy information or our site A-Z.
  • This article was published in April 2013. The information may be out of date. Please check our epilepsy information or our site A-Z.
  • This article was published in February 2013. The information may be out of date. Please check our epilepsy information or our site A-Z.
  • This article was published in January 2013. The information may be out of date. Please check our epilepsy information or our site A-Z.
  • This article was published in March 2011. The information may be out of date. Please check our epilepsy information or our site A-Z.

Stories about women

Topiramate may be linked to increased risk of birth defects in babies born to women taking the medicine

9 Jan 2018

TopirimateA new US study has found that taking the medicine topiramate during pregnancy may cause an increased risk of birth defects.

Topiramate is an epilepsy medicine sometimes used to treat generalised tonic-clonic seizures or focal seizures. This medicine can also be used for other conditions, such as bipolar disorder.

New study links sodium valproate to autism

26 Apr 2013

tabletsThere has been a scientific study carried out in Denmark. It looked at 650,000 children born between 1996 and 2006. The study found that the children’s risk of having any type of autism spectrum disorder was increased, when certain mothers took valproate during pregnancy.

There is already a known risk with taking sodium valproate during pregnancy. It increases the risk of children being born with birth defects and thinking problems. The new research also shows that valproate significantly increases the risk of having a child with autism or an autism spectrum disorder.

Pregnant women more likely to stop taking medication

28 Jan 2013

pregnant womanA UK study has found that pregnant women with epilepsy are more likely to stop taking their epilepsy medicines, compared to women who are not pregnant.

Researchers, led by Shuk-Li Man, analysed prescribing trends for anti-epileptic drugs from 1994 to 2009. The results show that prescribing of newer medicines has steadily increased. Lamotrigine has been the most popular medicine prescribed in pregnancy since 2004. However, the use of carbamazepine and sodium valporate has decreased.

Epilepsy and pregnancy survey: counselling is not happening

8 Jan 2013

Woman's pregnant bumpAs part of a new campaign that launches today, Epilepsy Action has released the results of a survey of women living with the condition. The survey results show that a concerning number of these women have not been properly informed by their healthcare professionals. Vital facts about epilepsy and pregnancy are not being given – facts that may help ensure the safety of both mother and child.

Subscribe to women